Rompag 50mg (Eltrombopag 50mg) Hobart — ITP & Aplastic
Anaemia Tasmania Australia 2026
Product Name
Rompag 50mg (Eltrombopag 50mg) Hobart — ITP & Aplastic Anaemia Treatment | Tasmania, Australia 2026
Product Details
Rompag 50mg contains Eltrombopag 50mg, a thrombopoietin receptor agonist (TPO-RA) used to increase platelet production in eligible patients with Chronic Immune Thrombocytopenia (ITP) who have had an insufficient response to other therapies. It is also indicated for selected patients with Severe Aplastic Anaemia (SAA) as prescribed by a hematology specialist.
At Unnati Pharmax, we export high-quality generic Eltrombopag tablets manufactured in WHO-GMP-certified Indian facilities to customers in Hobart, Tasmania, Australia, and other international markets, subject to local import regulations.
Product Specifications
| Brand Name | Rompag 50mg |
| Generic Name | Eltrombopag |
| Strength | 50 mg |
| Dosage Form | Tablets |
| Therapeutic Category | Hematology |
| Drug Class | Thrombopoietin Receptor Agonist (TPO-RA) |
| Indications | Chronic Immune Thrombocytopenia (ITP), Severe Aplastic Anaemia (SAA) in appropriate patients |
| Route of Administration | Oral |
| Storage | Store below 25°C in a cool, dry place away from moisture and sunlight |
| Prescription Required | Yes |
| Manufacturer | Indian WHO-GMP Certified Manufacturer |
| Export Availability | Hobart, Tasmania, Australia & International Markets |
Key Features
- Contains Eltrombopag 50mg
- Generic alternative to Promacta® / Revolade®
- Used for eligible patients with Chronic ITP and Severe Aplastic Anaemia
- Helps stimulate platelet production through TPO receptor activation
- Convenient oral tablet formulation
- Manufactured in WHO-GMP-certified facilities
- Export-quality packaging with strict quality control
- Competitive pricing for hospitals, pharmacies, and distributors
- Secure worldwide shipping from India
- Complete export documentation and parcel tracking available
Industry Update
Eltrombopag continues to play an important role in the treatment of Chronic Immune Thrombocytopenia (ITP) and selected patients with Severe Aplastic Anaemia (SAA). Current clinical practice emphasizes individualized treatment strategies based on platelet response, bleeding risk, and patient characteristics. Ongoing research is evaluating eltrombopag in combination with immunosuppressive therapies and other novel treatment approaches to improve long-term outcomes in bone marrow failure disorders. The increasing availability of high-quality generic eltrombopag has expanded access to treatment in many international markets while helping reduce healthcare costs. Treatment should always be initiated and monitored by a qualified hematologist according to current clinical guidelines.
Hobart's Royal Hobart Hospital haematology — Tasmania's sole comprehensive haematology service — manages ITP and aplastic anaemia for Australia's smallest and most geographically isolated state-capital population of 240,000. Tasmania's unique position — an island state 240km south of mainland Australia with its own distinctive health challenges — creates pharmaceutical supply vulnerabilities that mainland capitals don't experience. Rompag 50mg provides Hobart's thrombocytopenic patients with affordable Eltrombopag at dramatically reduced cost with supply chain independence from Bass Strait-dependent mainland supply.
Visit unnatipharmax.com | 📱 +91 82650 41513 | 📧 Unnatipharmax@gmail.com

FAQ 1: How does Tasmania's geographic isolation create unique Rompag supply chain vulnerabilities compared to mainland Australian cities?

FAQ 2: How does Tasmania's ageing population — Australia's oldest median age state — create elevated Rompag demand?

FAQ 3: How does Royal Hobart Hospital's sole haematology service manage ITP with Rompag for all of Tasmania?

FAQ 4: How does Tasmania's distinctive food culture — cool-climate produce, whisky, and artisan food — interact with Rompag's strict food timing?

FAQ 5: What evidence supports Rompag 50mg in improving surgical safety for Hobart's ITP patients needing operations?
Website
Email Id
Contact Number
+91-8265041513
Rompag-50-mg-Eltrombopag-50-mg-Hobart